Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.9%

6 terminated/withdrawn out of 634 trials

Success Rate

96.1%

+9.5% vs industry average

Late-Stage Pipeline

16%

99 trials in Phase 3/4

Results Transparency

1%

2 of 147 completed trials have results

Key Signals

215 recruiting2 with results5 withdrawn

Enrollment Performance

Analytics

N/A
256(55.8%)
Phase 3
52(11.3%)
Phase 2
47(10.2%)
Phase 4
47(10.2%)
Phase 1
32(7.0%)
Early Phase 1
25(5.4%)
459Total
N/A(256)
Phase 3(52)
Phase 2(47)
Phase 4(47)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (634)

Showing 20 of 634 trials
NCT07183670Enrolling By Invitation

A Voice Valve-Based Decannulation Protoco for Patients With a Prolonged Disorders of Consciousness

Role: collaborator

NCT06596681Early Phase 1Recruiting

A Study of the Safety and Tolerability of GA in the Treatment of Patients With Refractory Neuropathic Pain

Role: lead

NCT07737158Not ApplicableNot Yet Recruiting

Venlafaxine for Non-specific Low Back Pain

Role: lead

NCT06331923Not ApplicableCompleted

Assessing the Effectiveness of Continuous Glucose Monitoring in Enhancing Surgical Outcomes for Patients With Diabetes

Role: collaborator

NCT07084012Phase 2Recruiting

A Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of Intravenous Infusion of hUC-MSCs in Patients With AIS

Role: collaborator

NCT07709416Not ApplicableRecruiting

Toludesvenlafaxine for Non-specific Low Back Pain

Role: lead

NCT07572812Phase 1Not Yet Recruiting

A Phase I Clinical Trial of UX-GIP001 in the Treatment of Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy

Role: collaborator

NCT06101667Not ApplicableCompleted

Efficacy and Safety of Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)

Role: lead

NCT07028177Recruiting

Changes in Etomidate Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia

Role: lead

NCT07028190Recruiting

Changes in Rimazolen Dosage in Patients With Insomnia Under Intravenous Anesthesia

Role: lead

NCT06897007Recruiting

Changes in Ciprofol Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia

Role: lead

NCT07713745Phase 2Not Yet Recruiting

Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)

Role: lead

NCT07707076Not ApplicableRecruiting

Flow Diverter Versus Conventional Endovascular Treatment for Unruptured Wide-Neck Bifurcation Aneurysms (FD-BWA Trial)

Role: collaborator

NCT07708285Phase 1Not Yet Recruiting

Luvometinib in Combination With Serplulimab for NF2-Related Tumors

Role: lead

NCT07707947Phase 2Not Yet Recruiting

Selumetinib for NF2-Related Schwannomatosis

Role: lead

NCT04948749Not ApplicableRecruiting

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

Role: lead

NCT07704528Active Not Recruiting

Effect of Central Venous Catheterization on Brain Pressure in Acute Brain Injury Patients

Role: lead

NCT07695285Phase 2Not Yet Recruiting

Lemborexant Use for Cognition Improvement in Postoperative Delirium in Elderly Patients: A Randomized Controlled Trial

Role: lead

NCT07432711Not ApplicableRecruiting

The Efficacy and Safety of Liposomal Bupivacaine in Relieving Postoperative Pain After Video-assisted Thoracoscopic Surgery

Role: lead

NCT07698626Phase 1Not Yet Recruiting

Venlafaxine Combined With Education and Behavioral Intervention for Bladder Pain Syndrome

Role: lead